Therapeutic targeting of KRAS mutation-driven tumorigenesis by extracellular vesicles loaded with small interfering RNA
Zhai, Y.; Niu, S.; Qiu, T.; Yi, Y.; Yan, Y.; Hu, R.; He, X.; Xu, K.
Show abstract
RAS is a well-known oncogene contributing to significant proportion of cancer incidences, yet it remains as an undruggable target to majority of therapeutic modalities. Here, we explored the potential of extracellular vesicles (EVs) for therapeutic targeting of KRAS mutation-driven tumorigenesis. EVs loaded with small interfering RNA (siRNA) against KRAS successfully inhibited tumor xenograft growth when injected intratumorally in mice models. Intriguingly, when injected intravenously, EVs were still able to accumulate in tumors and deliver KRAS targeting siRNA payload in sufficient amount to show tumor growth inhibition. Therefore, EV-siRNA platform show great promises for therapeutic targeting of KRAS mutations and other undruggable targets.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dual Ligand Cooperation at the Plasma Membrane Drives Transport of Engineered Small Extracellular Vesicles Across Brain Endothelial Cells 94%
- Hybrid Adipocyte-Derived Exosome Nano Platform for Potent Chemo-Phototherapy in Targeted Hepatocellular Carcinoma 93%
- Unveiling the potential of neuron-targeted dendriplexes for siRNA delivery using a PNS-CNS-on-Chip 92%
Similar papers in this journal
- Scalable, high-throughput isolation of extracellular vesicles using electrokinetic-assisted mesh filtration 92%
- Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina 92%
- Oral delivery of semaglutide and tirzepatide using milk-derived small extracellular vesicles 92%
Similar papers in this journal
- An Immunogold Single Extracellular Vesicular RNA and Protein (AuSERP) Biochip to Predict Responses to Immunotherapy in Non-Small Cell Lung Cancer Patients 93%
- Engineering a Single Extracellular Vesicle Protein and RNA Assay (siEVPRA) via In Situ Fluorescence Microscopy in a UV Micropatterned Array 93%
- VesicleVoyager: In vivo selection of surface displayed proteins that direct extracellular vesicles to tissue-specific targets 92%
Similar papers in this journal
- An in situ generated CAR-M with IFNg and negative dominance Sirpa isoform augments hepatocellular carcinoma immunotherapy 92%
- Red Blood Cell-derived Extracellular Vesicles enable Cisplatin and Cetuximab Synergistic Therapy against Triple-Negative Breast Cancer 91%
- Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.